JD HEALTH
06618
BIDU-SW
09888
JD-SW
09618
ALI HEALTH
00241
BEKE-W
02423
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | |||||||||
Earning before tax | ---- | 48.68%-196.71M | ---- | -26.10%-383.29M | -59.88%-210.79M | -237.68%-303.95M | ---131.84M | 30.90%-90.01M | ---130.27M |
Profit adjustment | |||||||||
Impairment and provisions: | ---- | -19.08%140K | ---- | -44.19%173K | ---- | -89.70%310K | --293K | -91.03%3.01M | --33.56M |
-Other impairments and provisions | ---- | -19.08%140K | ---- | -44.19%173K | ---- | -89.70%310K | --293K | -91.03%3.01M | --33.56M |
Asset sale loss (gain): | ---- | -250.00%-21K | ---- | -91.30%14K | -76.92%24K | --161K | --104K | ---- | --1.56M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -250.00%-21K | ---- | -91.30%14K | -76.92%24K | --161K | --104K | ---- | --1.56M |
Depreciation and amortization: | ---- | 16.51%20.32M | ---- | 32.73%17.44M | 35.18%8.28M | 17.60%13.14M | --6.13M | 67.09%11.17M | --6.69M |
-Depreciation | ---- | 16.79%19.52M | ---- | 33.93%16.71M | 36.60%7.94M | 14.75%12.48M | --5.81M | 62.94%10.88M | --6.68M |
-Amortization of intangible assets | ---- | 10.11%795K | ---- | 10.06%722K | 9.40%349K | 123.13%656K | --319K | 2,840.00%294K | --10K |
Financial expense | ---- | 18.92%144.82M | ---- | 12.72%121.78M | 12.70%51.39M | 688.81%108.04M | --45.6M | 2,358.89%13.7M | --557K |
Exchange Loss (gain) | ---- | -78.88%28.44M | ---- | 587.28%134.66M | 803.44%74.93M | -2,950.22%-27.64M | ---10.65M | -253.30%-906K | --591K |
Special items | ---- | -61.66%5.23M | ---- | 72.67%13.65M | 23.98%7.05M | -47.10%7.9M | --5.69M | 368.11%14.94M | --3.19M |
Operating profit before the change of operating capital | ---- | 102.32%2.22M | ---- | 52.69%-95.58M | 18.39%-69.11M | -320.03%-202.04M | ---84.68M | 42.82%-48.1M | ---84.13M |
Change of operating capital | |||||||||
Inventory (increase) decrease | ---- | 35.85%-9.58M | ---- | 64.90%-14.94M | 89.42%-3.16M | 30.59%-42.56M | ---29.84M | -1,120.38%-61.31M | ---5.02M |
Accounts receivable (increase)decrease | ---- | 61.13%-14.87M | ---- | -441.06%-38.26M | -96.08%567K | 3.13%11.22M | --14.46M | 115.75%10.88M | ---69.05M |
Accounts payable increase (decrease) | ---- | 9.12%84.22M | ---- | 96.48%77.18M | 313.99%56.89M | -69.50%39.28M | --13.74M | 43.64%128.81M | --89.67M |
prepayments (increase)decrease | ---- | 184.57%45.53M | ---- | -887.20%-53.83M | 115.42%800K | -214.48%-5.45M | ---5.19M | -4,546.15%-1.73M | --39K |
Special items for working capital changes | ---- | -212.83%-85.15M | ---- | 1,957.42%75.47M | 490.00%11.39M | 36.44%-4.06M | ---2.92M | -199.86%-6.39M | --6.4M |
Cash from business operations | 3.70%31.38M | 144.74%22.36M | 1,252.36%30.26M | 75.46%-49.96M | 97.22%-2.63M | -1,019.50%-203.61M | ---94.43M | 135.66%22.14M | ---62.09M |
Other taxs | 62.75%-19K | -7,300.00%-74K | ---51K | 97.62%-1K | ---- | -366.67%-42K | ---17K | -350.00%-9K | ---2K |
Net cash from operations | 3.81%31.36M | 144.60%22.28M | 1,250.42%30.21M | 75.47%-49.97M | 97.22%-2.63M | -1,020.06%-203.66M | ---94.45M | 135.65%22.14M | ---62.09M |
Cash flow from investment activities | |||||||||
Dividend received - investment | ---- | ---- | ---- | ---2M | ---- | ---- | ---- | ---- | ---- |
Loan receivable (increase) decrease | ---- | -44.29%12.03M | -2.94%12.03M | 134.94%21.6M | -1.18%12.4M | 111.38%9.19M | --12.55M | -809.03%-80.78M | ---8.89M |
Sale of fixed assets | ---- | --34K | --3K | ---- | ---- | ---- | ---- | ---- | ---- |
Purchase of fixed assets | 1.84%-2.56M | -6.95%-5.65M | -11.98%-2.61M | 4.24%-5.28M | 14.31%-2.33M | -11.21%-5.52M | ---2.72M | -73.27%-4.96M | ---2.86M |
Acquisition of subsidiaries | ---- | ---- | ---- | ---- | ---2M | ---- | ---- | ---- | ---- |
Recovery of cash from investments | ---- | --10M | --10M | ---- | ---- | ---- | ---- | ---- | ---- |
Cash on investment | ---- | ---- | ---- | ---- | ---- | -300.00%-8M | ---8M | ---2M | ---- |
Net cash from investment operations | -113.18%-2.56M | 14.69%16.42M | 140.79%19.43M | 431.14%14.32M | 341.60%8.07M | 95.07%-4.32M | --1.83M | -646.81%-87.74M | ---11.75M |
Net cash before financing | -41.97%28.8M | 208.56%38.7M | 812.11%49.64M | 82.86%-35.65M | 105.88%5.44M | -217.04%-207.98M | ---92.62M | 11.16%-65.6M | ---73.84M |
Cash flow from financing activities | |||||||||
New borrowing | 220.00%16M | 3.27%25.6M | -66.19%5M | --24.79M | --14.79M | ---- | ---- | ---- | ---- |
Refund | -10.00%-11M | -106.90%-30.6M | ---10M | ---14.79M | ---- | ---- | ---- | ---- | ---- |
Issuing shares | ---- | ---- | ---- | --110.18M | --50.72M | ---- | ---- | --294.7M | ---- |
Interest paid - financing | -32.74%-1.12M | -76.60%-1.79M | -103.37%-846K | -24.29%-1.01M | -6.67%-416K | 11.61%-815K | ---390K | -65.53%-922K | ---557K |
Absorb investment income | ---- | ---- | ---- | ---- | ---- | -99.48%303K | ---- | -89.96%57.81M | --575.78M |
Other items of the financing business | -890.28%-31.61M | 77.54%-5.62M | --4M | -8,150.83%-25M | ---- | ---303K | ---- | ---- | ---485.04M |
Net cash from financing operations | -280.01%-37.04M | -135.64%-29.31M | -116.36%-9.75M | 820.90%82.23M | 1,307.97%59.57M | -103.32%-11.41M | ---4.93M | 299.60%343.49M | --85.96M |
Effect of rate | -89.69%336K | -44.95%2.02M | 31.05%3.26M | 197.14%3.67M | 194.31%2.49M | -101.82%-3.77M | ---2.64M | -216.41%-1.87M | ---591K |
Net Cash | -120.64%-8.23M | -79.84%9.39M | -38.64%39.89M | 121.23%46.58M | 166.64%65.01M | -178.95%-219.39M | ---97.56M | 2,193.22%277.89M | --12.12M |
Begining period cash | 8.46%146.32M | 59.36%134.91M | 59.36%134.91M | -72.50%84.66M | -72.50%84.66M | 868.16%307.82M | --307.82M | 56.88%31.79M | --20.27M |
Cash at the end | -22.26%138.42M | 8.46%146.32M | 17.03%178.06M | 59.36%134.91M | -26.72%152.15M | -72.50%84.66M | --207.63M | 868.16%307.82M | --31.79M |
Cash balance analysis | |||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.